Intelligent Bio Solutions (INBS) Investor presentation summary

Business overview and mission

• Focuses on delivering intelligent, rapid, non-invasive drug testing solutions to improve quality of life and transform testing approaches.

• Utilizes fingerprint sweat analysis for portable, efficient, and cost-effective drug screening.

• Targets recent drug use detection, emphasizing workplace safety and fitness for duty.

Technology and product features

• Drug screening system detects metabolites in fingerprint sweat, identifying recent misuse within 16–24 hours.

• Three-step process delivers results in under 10 minutes, with ongoing validation for even faster testing.

• Offers high accuracy (up to 99%), lower annual costs, and greater efficiency compared to urine and saliva tests.

• Portable, hygienic, and preserves dignity and privacy during testing.

Market opportunity and drivers

• Global drug screening market valued at $12.6B in 2024, projected to reach $31.8B by 2030 (CAGR 16.7%).

• U.S. market valued at $3.5B in 2024, with strong growth and demand for rapid, high-throughput solutions.

• Market growth driven by regulations, workplace safety, rising substance abuse, and demand for non-invasive testing.